Sennosides Tablet
Product Images NDC 62993-0001

15 FDA label images from Morepen Laboratories Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Sennosides (NDC 62993-0001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Morepen Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Active Ingredient Label (Active Ingredient)

Active Ingredient Label (Active Ingredient)
Drug Facts label panel showing the active ingredient Sennosides at 8.6 mg per tablet and its purpose listed as laxative. The text is presented in a black and white boxed format with bold headers.*
FDA Label Image

Purpose (Purpose)

Purpose (Purpose)
A partial Drug Facts panel showing the active ingredient section for Sennosides tablets. It specifies each tablet contains 8.6 mg of Sennosides, listed as a laxative.*
FDA Label Image

Indications & Usage (Uses)

Indications & Usage (Uses)
Drug Facts panel titled Uses, indicating the product relieves occasional constipation (irregularity) and generally produces a bowel movement in 6-12 hours.*
FDA Label Image

Dosage & Administration (Dosage And Administration)

Dosage & Administration (Dosage And Administration)
Directions panel showing dosing recommendations for Sennosides tablets by age group. It lists starting and maximum dosages for adults and children 12 years and over, children 6 to under 12 years, children 2 to under 6 years, and advises consulting a doctor for children under 2 years. The label advises taking preferably at bedtime or as directed by a doctor.*
FDA Label Image

Inactive Ingredients (Inactive Ingredient)

Inactive Ingredients (Inactive Ingredient)
Label excerpt listing inactive ingredients for Sennosides tablets, including croscarmellose sodium, dibasic calcium phosphate, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone, and polyethylene glycol.*
FDA Label Image

Questions Section Label (Questions Comments)

Questions Section Label (Questions Comments)
A text panel titled 'Question or comments?' providing a toll-free phone number +1-844-524-5035 available Monday to Friday from 9 AM to 5 PM EST, an email address [email protected], and contact information for the FDA including phone number 1-800-FDA-1088 and the website www.fda.gov/medwatch.*
FDA Label Image

Warnings (Warnings Section)

Warnings (Warnings Section)
Drug facts warning panel for Sennosides oral tablets. It advises not to use laxatives for more than 1 week without doctor approval, to consult a doctor before use if experiencing stomach pain, nausea, vomiting, or significant changes in bowel habits. It instructs to stop use and seek medical advice if rectal bleeding occurs or bowel movements fail. Additional warnings include consulting a professional if pregnant or breastfeeding and keeping the product away from children.*
FDA Label Image

Keep Out Of Reach Of Children (Keep Out Of Reach Children)

Keep Out Of Reach Of Children (Keep Out Of Reach Children)
A drug facts panel warning that reads: Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.*
FDA Label Image

Storage And Handling (Storage And Handling)

Storage And Handling (Storage And Handling)
This image shows a drug facts panel titled 'Other information' for Sennosides tablets. It states that each tablet contains 26.9 mg of calcium and includes storage instructions recommending to store at 25°C (77°F) with permitted temperature excursions between 15-30°C (59-86°F).*
FDA Label Image

Primary Display Panel 30 Tablets (30 Pdp)

Primary Display Panel 30 Tablets (30 Pdp)
Sennosides Tablets 8.6 mg oral tablets by Morepen Laboratories Limited. The label states it is a standardized senna concentrate with regular strength for constipation relief. The package contains 30 tablets distributed by Morepen Bio Inc. The label also includes a barcode, usage warnings, directions, and inactive ingredients information.*
FDA Label Image

Primary Display Panel 100 Tablets (100 Pdp)

Primary Display Panel 100 Tablets (100 Pdp)
Sennosides Tablets 8.6 mg oral tablets by Morepen Laboratories Limited. The label shows packaging for 100 tablets, with each tablet containing standardized senna concentrate 8.6 mg. The label includes drug facts, uses, warnings, dosage instructions by age group, and other product information along with barcode and distribution/manufacturing details.*
FDA Label Image

Primary Display Panel 250 Tablets (250 Pdp)

Primary Display Panel 250 Tablets (250 Pdp)
Sennosides Tablets 8.6 mg oral tablets by Morepen Laboratories Limited, distributed by Morepen Bio Inc. The label states standardized Senna concentrate 8.6 mg with 250 tablets per container. It includes a barcode and warnings about seal integrity and product authenticity.*
FDA Label Image

Primary Display Panel 1000 Tablets (1000 Pdp)

Primary Display Panel 1000 Tablets (1000 Pdp)
Drug Facts panel for Sennosides Tablets 8.6 mg by Morepen Laboratories Limited. The label includes active ingredient, purpose, uses, warnings, directions for dosage by age group, inactive ingredients, and manufacturer and distributor information. The product contains 1000 tablets in total.*
FDA Label Image

Primary Display Panel 3000 Tablets (3000 Pdp)

Primary Display Panel 3000 Tablets (3000 Pdp)
Sennosides Tablets 8.6 mg oral tablets by Morepen Laboratories Limited. The label highlights the active ingredient sennosides 8.6 mg per tablet offering laxative relief for constipation. It mentions 3000 tablets package size and includes directions, warnings, inactive ingredients, and contact information for the manufacturer and distributor.*
FDA Label Image

Primary Display Panel 30000 Tablets (30000 Pdp)

Primary Display Panel 30000 Tablets (30000 Pdp)
Front and back label of Dr. Morepen Sennosides Tablets, 8.6 mg oral tablets with 30,000 count. The label states it is a standardized senna concentrate and mentions the product provides gentle constipation relief. The back includes drug facts such as active ingredient Sennosides 8.6 mg as a laxative, usage directions, warnings, and inactive ingredients. Manufacturer information lists Morepen Laboratories Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.